QBE North America Introduces Life Sciences Insurance Offering
QBE North America (OTC:QBIEY) has launched a comprehensive Life Sciences insurance product designed to protect medical product developers, manufacturers, and distributors. The new offering provides liability coverage across multiple areas including clinical trials, dental and medical devices, specialty pharmaceuticals, and animal health products.
The product features primary and excess liability coverages including products completed operations, clinical trial liability, errors and omissions, general liability, and healthcare professional liability. This launch follows QBE's 2024 introduction of Miscellaneous Medical Liability products and expands their Healthcare Liability portfolio. In 2024, QBE North America reported Gross Written Premiums of $7.3 billion.
QBE North America (OTC:QBIEY) ha lanciato un prodotto assicurativo completo per le Scienze della Vita, pensato per proteggere sviluppatori, produttori e distributori di prodotti medici. La nuova offerta copre la responsabilit脿 in diversi ambiti, tra cui studi clinici, dispositivi dentali e medici, farmaci speciali e prodotti per la salute animale.
Il prodotto include coperture di responsabilit脿 primaria e supplementare, comprendendo responsabilit脿 per prodotti e operazioni completate, responsabilit脿 per studi clinici, errori e omissioni, responsabilit脿 generale e responsabilit脿 dei professionisti sanitari. Questo lancio segue l'introduzione nel 2024 da parte di QBE dei prodotti di Responsabilit脿 Medica Varie, ampliando il loro portafoglio di Responsabilit脿 Sanitaria. Nel 2024, QBE North America ha registrato premi lordi di 7,3 miliardi di dollari.
QBE North America (OTC:QBIEY) ha lanzado un producto integral de seguros para Ciencias de la Vida, dise帽ado para proteger a desarrolladores, fabricantes y distribuidores de productos m茅dicos. La nueva oferta proporciona cobertura de responsabilidad en m煤ltiples 谩reas, incluyendo ensayos cl铆nicos, dispositivos dentales y m茅dicos, productos farmac茅uticos especializados y productos para la salud animal.
El producto cuenta con coberturas de responsabilidad primaria y adicional, incluyendo responsabilidad por productos y operaciones terminadas, responsabilidad en ensayos cl铆nicos, errores y omisiones, responsabilidad general y responsabilidad profesional sanitaria. Este lanzamiento sigue a la introducci贸n en 2024 por parte de QBE de productos de Responsabilidad M茅dica Diversa, ampliando su cartera de Responsabilidad Sanitaria. En 2024, QBE North America report贸 primas brutas emitidas por 7.3 mil millones de d贸lares.
QBE North America (OTC:QBIEY)電� 鞚橂 鞝滍拡 臧滊皽鞛�, 鞝滌“鞐呾泊 氚� 鞙犿喌鞐呾泊毳� 氤错樃頃橁赴 鞙勴暣 膦呿暕鞝侅澑 靸濍獏瓿柬暀 氤错棙 靸來拡鞚� 於滌嫓頄堨姷雼堧嫟. 鞚� 靸堧鞖� 靸來拡鞚� 鞛勳儊 鞁滍棙, 旃橁臣 氚� 鞚橂 旮瓣赴, 鞝勲 鞚橃暯頀� 氚� 霃欕 瓯搓皶 鞝滍拡 霌� 鞐煬 攵勳暭鞐� 瓯胳箿 毂呾瀯 氤挫灔鞚� 鞝滉车頃╇媹雼�.
鞚� 靸來拡鞚� 鞕勳劚霅� 鞝滍拡 氚� 鞛戩梾, 鞛勳儊 鞁滍棙 毂呾瀯, 鞓る 氚� 雸勲澖, 鞚茧皹 毂呾瀯, 鞚橂 鞝勲臧� 毂呾瀯鞚� 韽暔頃� 旮半掣 氚� 齑堦臣 毂呾瀯 氤挫灔鞚� 韸轨鞙茧 頃╇媹雼�. 鞚措矆 於滌嫓電� QBE臧� 2024雲勳棎 於滌嫓頃� 雼れ枒頃� 鞚橂 毂呾瀯 靸來拡鞐� 鞚挫潃 瓴冹溂搿�, 項姢旒�鞏� 毂呾瀯 韽姼韽措Μ鞓るゼ 頇曥灔頃╇媹雼�. 2024雲� QBE North America電� 73鞏� 雼煬鞚� 齑� 氤错棙耄�毳� 氤搓碃頄堨姷雼堧嫟.
QBE North America (OTC:QBIEY) a lanc茅 un produit d'assurance complet pour les Sciences de la Vie, destin茅 脿 prot茅ger les d茅veloppeurs, fabricants et distributeurs de produits m茅dicaux. Cette nouvelle offre couvre la responsabilit茅 dans plusieurs domaines, notamment les essais cliniques, les dispositifs dentaires et m茅dicaux, les produits pharmaceutiques sp茅cialis茅s et les produits de sant茅 animale.
Le produit propose des couvertures de responsabilit茅 primaire et exc茅dentaire, incluant la responsabilit茅 des produits et op茅rations termin茅es, la responsabilit茅 des essais cliniques, les erreurs et omissions, la responsabilit茅 g茅n茅rale et la responsabilit茅 des professionnels de sant茅. Ce lancement fait suite 脿 l'introduction par QBE en 2024 de produits de responsabilit茅 m茅dicale diversifi茅e, 茅largissant ainsi leur portefeuille de responsabilit茅 sant茅. En 2024, QBE North America a d茅clar茅 des primes brutes 茅mises de 7,3 milliards de dollars.
QBE North America (OTC:QBIEY) hat ein umfassendes Versicherungsprodukt f眉r Life Sciences eingef眉hrt, das Entwickler, Hersteller und Vertreiber medizinischer Produkte sch眉tzt. Das neue Angebot bietet Haftpflichtdeckung in mehreren Bereichen, darunter klinische Studien, Zahn- und Medizinprodukte, Spezialpharmazeutika und Tiergesundheitsprodukte.
Das Produkt umfasst prim盲re und zus盲tzliche Haftpflichtversicherungen, darunter Produkthaftung f眉r abgeschlossene Arbeiten, Haftpflicht bei klinischen Studien, Fehler und Unterlassungen, allgemeine Haftpflicht sowie Haftpflicht f眉r Gesundheitsfachkr盲fte. Dieser Start folgt auf die Einf眉hrung von QBE im Jahr 2024 von Produkten zur sonstigen medizinischen Haftpflicht und erweitert ihr Portfolio im Bereich Gesundheitswesen-Haftpflicht. Im Jahr 2024 meldete QBE North America Bruttobeitr盲ge in H枚he von 7,3 Milliarden US-Dollar.
- None.
- None.
"Life sciences companies face a unique and fast-changing risk landscape," said Lisa McCormack, vice president, underwriting leader 鈥� Life Sciences, QBE North America. "Our new offering is tailored to meet the specific coverage needs of these businesses as they continue to innovate and advance health care."
The Life Sciences product provides liability protection for a wide range of classifications, including clinical trials, dental and medical devices, personal care, specialty pharmaceuticals, animal health products, and more.
QBE offers primary and excess Life Sciences liability coverages such as:
- Products completed operations
- Clinical trial liability
- Errors and omissions (E&O)
- General liability
- Healthcare professional liability
"Our new Life Sciences product offers flexible and comprehensive coverage," said John Livatino, senior vice president, head of Healthcare Liability, QBE North America. "By leveraging our suite of Healthcare Liability solutions, we can also expand coverage for life sciences companies to include areas like medical professional liability and technology. Whether it's Life Sciences, Digital Health or Miscellaneous Medical Liability, we're committed to providing a comprehensive insurance solution to these organizations."
The launch expands QBE's Healthcare Liability portfolio following the introduction of its Miscellaneous Medical Liability product in 2024. That offering includes coverages for professional liability, physical & sexual misconduct liability, general liability, employee benefits liability, E&O, tech & media liability and excess/umbrella.
More information about QBE's Life Sciences product is available at聽.听
About QBE North America
QBE North America is a global insurance leader helping customers solve unique risks, so they can stay focused on their future. Part of聽QBE Insurance Group Limited, QBE North America reported Gross Written Premiums in 2024 of
View original content to download multimedia:
SOURCE QBE North America
FAQ
What new insurance products did QBE North America (QBIEY) launch in 2025?
What types of coverage does QBE's new Life Sciences insurance product include?
What was QBE North America's Gross Written Premium in 2024?
What industries are covered under QBE's new Life Sciences insurance offering?
How does the 2025 Life Sciences product launch relate to QBE's previous insurance offerings?
